Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Intangibles (2017 - 2025)

BioCorRx (BICX) has disclosed Intangibles for 11 consecutive years, with $249500.0 as the latest value for Q4 2025.

  • Quarterly Intangibles rose 3079.15% to $249500.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $249500.0 through Dec 2025, up 3079.15% year-over-year, with the annual reading at $249500.0 for FY2025, 3079.15% up from the prior year.
  • Intangibles hit $249500.0 in Q4 2025 for BioCorRx, down from $3.1 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $3.1 million in Q1 2025 to a low of $7848.0 in Q4 2024.
  • Historically, Intangibles has averaged $384529.8 across 5 years, with a median of $10353.5 in 2022.
  • Biggest five-year swings in Intangibles: crashed 93.28% in 2022 and later skyrocketed 36406.54% in 2025.
  • Year by year, Intangibles stood at $11385.0 in 2021, then dropped by 10.36% to $10206.0 in 2022, then decreased by 11.55% to $9027.0 in 2023, then fell by 13.06% to $7848.0 in 2024, then soared by 3079.15% to $249500.0 in 2025.
  • Business Quant data shows Intangibles for BICX at $249500.0 in Q4 2025, $3.1 million in Q2 2025, and $3.1 million in Q1 2025.